Over 8 million for research on systemic sclerosis

Radstake Tim

Timothy Radstake, Department of Rheumatology at the University Medical Center St. Radboud, together with Prof. R. Lafyatis, Prof. R. Simms and Prof. H. Farber (Boston University Medical Center) Prof. M. Withfield (Dartmouth Medical School) and Prof. J. Varga (Northwestern University School of Medicine, Chicago) got U.S. CORT grant awarded encompassing a total of eight million U.S. dollars over the next five years.

The American research institute (NIH) wants to support research into early diagnosis, treatment and pathogenesis of systemic sclerosis. With about one million U.S. dollars for Nijmegen, the Division of Rheumatology will have a substantial part of the proposed experiments performed in the laboratory of Rheumatology.

The award of this large grant is the result of a unique collaboration that came about partly by the position of Dr. Radstake as an associate professor at Boston University Medical Center. All are principal investigators on this grant. All researchers involved are authorities in the field of systemic sclerosis. Systemic sclerosis is an autoimmune disease characterized by excessive scarring of skin and internal organs like lungs, heart and intestines. There is no effective therapy for this serious condition. The present project aims to increase understanding of early diagnostic markers and to detect patients with a rapidly progressive course. In addition, this research is setup to better understand the etiology of the disease.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris ligula justo, imperdiet a facilisis ut, luctus quis tellus. Praesent placerat, enim vitae vehicula porta, sem urna euismod quam, sit amet accumsan dolor enim nec leo. Maecenas orci arcu, tincidunt dignissim dignissim vel, viverra in nisl. Nam felis lectus, dapibus ut pharetra a, rutrum blandit ipsum. Maecenas sollicitudin enim ut leo fringilla luctus blandit ipsum dictum. Etiam ac dolor nec urna ornare vehicula et at sem. Ut ac dictum dolor. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Mauris eu magna in neque rhoncus accumsan. Nam eget quam eu arcu cursus egestas. Pellentesque ac orci purus. Aliquam sed nisl et ipsum condimentum mattis in nec arcu. Aenean aliquet, justo et euismod molestie, tortor lacus lobortis eros, nec ullamcorper ligula quam eget neque.


<< back to overview news items